Advancium Health Network Names Michele Cleary CEO to Drive Next Phase of Pediatric Healthcare Innovation [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
Dr. Cleary, previously Advancium's President and Chief Scientific Officer, brings more than two decades of leadership in scientific innovation, drug development, and patient advocacy to her new role. "Michele's elevation to CEO reflects her unwavering dedication and proven ability to deliver results, " said Ron Mitchell, Advancium Health Network Board of Directors and Managing Partner at Low Post Ventures. "She has already transformed our approach to pediatric drug development—building partnerships, identifying a strategic pipeline of high-impact programs, and creating models that challenge conventional timelines. Her leadership positions us to achieve breakthroughs that families urgently need." Dr. Cleary's expertise spans translational research, clinical development strategy, FDA engagement, and organizational leadership. Prior to joining Advancium, she held senior leadership roles at Bristol Myers Squibb and Merck Research Laboratories; led academic partnerships for Deerfield D
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Why Bristol-Myers Squibb (BMY) Stock Is Up Today [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb (NYSE:BMY) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $61.00 price target on the stock, up previously from $52.00.MarketBeat
- How Investors May Respond To Bristol Myers (BMY) Dividend Hike And Oncology Pipeline Momentum [Yahoo! Finance]Yahoo! Finance
- 2 Dividend Stocks to Double Up on Right Now [Yahoo! Finance]Yahoo! Finance
- The Smartest Dividend Stocks to Buy With $1,000 Right Now [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 10/31/25 - Beat
BMY
Sec Filings
- 11/18/25 - Form 8-K
- 11/12/25 - Form CERT
- 11/10/25 - Form 8-A12B
- BMY's page on the SEC website